By transforming human scar cells into blood vessel cells, scientists at Houston Methodist may have discovered a new way to repair damaged tissue.
The method, described in an upcoming issue of Circulation (early online), appeared to improve blood flow, oxygenation, and nutrition to areas in need.
Cardiovascular scientists at Houston Methodist, with colleagues at Stanford University and Cincinnati Children’s Hospital, learned that fibroblasts — cells that causes scarring and are plentiful throughout the human body — can be coaxed into becoming endothelium, an entirely different type of adult cell that forms the lining of blood vessels.
“To our knowledge, this is the first time that trans-differentiation to a therapeutic cell type has been accomplished with a small molecules and proteins,” said Houston Methodist Research Institute Department of Cardiovascular Sciences Chair John Cooke, M.D., Ph.D., the study’s principal investigator. “In this particular case, we’ve found a way to turn fibroblasts into ‘shapeshifters’ nearly on command.”
Cooke said the regenerative medicine approach provides proof-of-concept for a small molecule therapy that could one day be used to improve the healing of cardiovascular damage or other injuries.
Other research groups have managed to generate endothelial cells cells using infectious virus particles specially engineered to deliver gene-manipulating DNA to cells. The DNA encodes proteins called transcription factors to alter gene expression patterns in such a way that cells behave more like endothelial cells.
“There are problems with using viruses to transfer genes into cells,” Cooke said. “This gene therapy approach is more complicated, and using viral vectors means the possibility of causing damage to the patient’s chromosomes. We believe a small-molecule approach to transforming the cells will be far more feasible and safer for clinical therapies.”
The Latest on: Reprogrammed cells
[google_news title=”” keyword=”Reprogrammed cells” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Reprogrammed cells
- Heart Health: Understanding Stem Cells And Its Role In Cardiac Careon March 28, 2024 at 12:29 am
Stem cell therapy holds tremendous potential to revolutionise cardiac care by offering a regenerative approach to treating heart diseases Read on ...
- New immunotherapy could make blood more 'youthful,' mouse study hintson March 27, 2024 at 9:00 am
such as T and B cells. Related: 'If you don't have inflammation, then you'll die': How scientists are reprogramming the body's natural superpower As we age, the HSCs slated to become myeloid cells ...
- A Groundbreaking "De-Extinction Project" Aims To Revive The Woolly Mammoth, A Species That's Been Extinct For Over 4,000 Years, Using Stem Cell Reprogrammingon March 26, 2024 at 4:00 pm
By 2028, woolly mammoths may return to life after being extinct for over 4,000 years. Researchers from the de-extinction company Colossal Biosciences have successfully created stem cells that can grow ...
- Studying use of patients’ own reprogrammed cells to attack cancer as alternative to more chemoon March 25, 2024 at 5:00 pm
DENVER — A process of taking patients’ own cells and reprogramming them to fight cancer has been a last-ditch option for blood cancer patients when nothing else worked, but a new study ...
- Sam Altman's mission to increase human lifespan with a $180 million shipping container experiment at Retro Bioscienceson March 23, 2024 at 2:46 am
Sam Altman started a $180 million side project called Retro Biosciences, hoping to add 10 healthy, enjoyable years onto the back end of our lifespans.
- Cell Therapy Takes Aim at Deadly Brain Tumors in Two Clinical Trialson March 21, 2024 at 4:58 pm
Two studies genetically engineered immune cells to hunt down and wipe out brain tumors. The results aren't a home run, but they do offer a ray of hope.
- Capstan heats up ‘in vivo’ cell therapy chase with $175M fundraiseon March 20, 2024 at 7:56 am
The high-profile startup, co-founded by CAR-T innovator Carl June, will use the funds to bring an autoimmune disease treatment into proof-of-concept studies.
- New technique for Parkinson’s stem cell brain repair brings promise for patientson March 19, 2024 at 6:55 am
Neuroscientists at University of Galway have made an exciting discovery that could revolutionise stem cell-based brain repair therapy for Parkinson’s disease.
- CHOP study uncovers metabolic key to faster immune responseon March 17, 2024 at 9:36 am
Researchers from Children's Hospital of Philadelphia identified a key metabolite in cells that helps direct immune responses and explains at a single cell level why immune cells that most efficiently ...
- Asgard Gets $32M Series A Backing from J&J, Novo and Boehringeron March 15, 2024 at 8:48 am
Asgard Therapeutics, a Swedish gene therapy biotech, has closed a $32 million Series A round with help from prominent pharma players as it prepares for a 2026 IND.
via Bing News